Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.
Heartseed has raised $14.3M in total funding. The most recent round was Series D. The last funding was announced in May 2023.
Heartseed's investors include SBI Investment, SMBC Venture Capital, Nissay Capital, Sumitomo Mitsui Trust Investment, Keio Innovation Initiative.
Heartseed is headquartered in Tokyo, Japan.
Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.
Heartseed is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Heartseed — Funding & Investors." VCBacked, May 25, 2023, https://www.vcbacked.co/company/heartseed. Accessed July 19, 2026.
VCBacked. (2023). Heartseed — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/heartseed
{{cite web |title=Heartseed — Funding & Investors |url=https://www.vcbacked.co/company/heartseed |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated